GRCE

Grace Therapeutics, Inc. Common Stock
GRCE

Overview Fund Activity

24 hedge funds and large institutions have $258K invested in Grace Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$12K
2
AAS
2
Avantax Advisory Services
Texas
$3K
3
TSS
3
Two Sigma Securities
New York
$3K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
JLBC
3
J.L. Bainbridge & Co
Florida
$0
4
VF
4
Virtu Financial
New York
$27K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$57K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$0 2,100 -4,361 -67%
Barclays
27
Barclays
United Kingdom
$0 34 – –
Rockefeller Capital Management
28
Rockefeller Capital Management
New York
$0 3,000 – –
AF
29
Advisornet Financial
Minnesota
$0 300 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
ASN
31
Advisory Services Network
Georgia
$0 2,000 +2,000 New
SXL
32
Summit X LLC
Missouri
$0 25,000 +25,000 New
1
2